Introduction - Prof Alfonso Cruz-Jentoft

Mild cognitive impairment (MCI) refers to a transitional stage between normal aging and dementia. MCI is defined by an objective decline in cognitive functioning (using appropriate cognitive tests) that exceeds the expected level given the patient’s age and education. 
In this context, this satellite symposium  intends to enhance the understanding of MCI within geriatric science, to ensure a better understanding of the role that MCT can play to supply energy to brain, and to present the results of innovative Oral Nutritional Supplement containing  ketogenic medium chain triglyceride  in MCI patients.